Guillain-Barre syndrome
Information
- Disease name
- Guillain-Barre syndrome
- Disease ID
- DOID:12842
- Description
- "An autoimmune disease of peripheral nervous system that causes body's immune system to attack part of the peripheral nervous system." [url:http\://www.ninds.nih.gov/disorders/gbs/gbs.htm]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05491096 | Completed | N/A | Effects of Proprioceptive Neuromuscular Training on Sensory and Motor Function in Guillain Barre Syndrome | June 5, 2022 | February 28, 2023 |
| NCT00575653 | Completed | Safety Study of GBS Following Menactra Meningococcal Vaccination | March 2005 | December 31, 2010 | |
| NCT01005524 | Completed | Brain Computer Interface for Communication in ICU: a Feasibility Study | January 2010 | May 2012 | |
| NCT01370200 | Completed | N/A | Regional Citrate Anticoagulation in Plasma Exchange Treatment | April 2011 | December 2014 |
| NCT06334796 | Completed | Early Phase 1 | Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology | October 1, 2023 | January 1, 2024 |
| NCT03206541 | Completed | Neurologic Manifestations of the Arbovirus Infection in Colombia | January 1, 2016 | December 31, 2019 | |
| NCT03826056 | Completed | N/A | Neurology Inpatient Clinical Education Trial | February 1, 2019 | December 7, 2021 |
| NCT03941184 | Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity | January 1, 1995 | November 10, 2020 | |
| NCT00056810 | Completed | Phase 2 | Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine | September 2002 | May 2005 |
| NCT05945784 | Completed | Exploring Accessible Beauty for Individuals With Upper Extremity Deficits | July 21, 2023 | September 29, 2023 | |
| NCT04752566 | Completed | Phase 3 | A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome | March 8, 2021 | August 3, 2022 |
| NCT04927598 | Completed | Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome | October 20, 2020 | April 1, 2022 | |
| NCT05104762 | Completed | Phase 2/Phase 3 | IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients | September 1, 2021 | March 3, 2023 |
| NCT05292690 | Completed | An Assistive Powered Wheelchair: Stage 2 Trial | March 29, 2021 | August 31, 2021 | |
| NCT05324176 | Completed | N/A | Diaphragm Thickness by Ultrasonography in Neurological Disorders | April 13, 2022 | May 13, 2022 |
| NCT05284786 | Not yet recruiting | Ultrasonography and Electrophysiology in GBS | July 1, 2022 | October 1, 2024 | |
| NCT06300359 | Not yet recruiting | Prognostic Indicators of Gullian-Barre Syndrome | March 2024 | June 2025 | |
| NCT06200454 | Not yet recruiting | Predictive Value of Neuromuscular Ultrasound of Cranial Nerves in Guillain-Barré Syndrome | January 8, 2024 | June 8, 2025 | |
| NCT05940922 | Not yet recruiting | RWE-based Treatment Patterns and Outcomes in CIDP | August 17, 2023 | October 30, 2023 | |
| NCT05114941 | Not yet recruiting | N/A | Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome | June 1, 2024 | December 31, 2024 |
| NCT05701189 | Not yet recruiting | Phase 2 | Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome | May 2024 | May 2027 |
| NCT04701164 | Recruiting | Phase 3 | Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome | December 17, 2020 | April 30, 2024 |
| NCT03840928 | Recruiting | PatientSpot Formerly Known as ArthritisPower | April 1, 2015 | March 1, 2025 | |
| NCT06167239 | Recruiting | N/A | Ventilator Trigger Sensitivity Adjustment Versus Threshold Inspiratory Muscle Training on Arterial Blood Gases | December 2, 2023 | May 2024 |
| NCT06032741 | Recruiting | Prognosis in Patients With Guillain-Barre Syndrome | January 2, 2013 | January 31, 2025 | |
| NCT04249752 | Recruiting | Biomarkers in Polyradiculoneuropathies | January 1, 2020 | January 30, 2025 | |
| NCT04303962 | Recruiting | Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome | April 27, 2020 | January 21, 2025 | |
| NCT05630313 | Recruiting | Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil | October 4, 2022 | September 30, 2023 | |
| NCT06041451 | Recruiting | Phase 4 | Early and Late Prognosis in Patients With Guillain-Barre Syndrome | January 2, 2013 | January 31, 2025 |
| NCT00004833 | Terminated | N/A | Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome | July 1995 | November 2002 |
| NCT04053452 | Terminated | N/A | Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome | September 30, 2019 | February 5, 2024 |
| NCT02582853 | Unknown status | sCD163 as a Potential Biomarker in Guillain- Barré Syndrome | September 2015 | January 2018 | |
| NCT04092140 | Unknown status | Neuromuscular Ultrasound in Correlation to Neurophysiological Findings | October 1, 2019 | November 2022 | |
| NCT01655394 | Unknown status | Change of Nerve Conduction Properties in IVIg Dependent Neuropathies | October 2012 | June 2016 | |
| NCT03801135 | Unknown status | N/A | Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation | October 3, 2018 | September 24, 2019 |
| NCT04550611 | Unknown status | N/A | Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome | November 2021 | December 2022 |
| NCT03268304 | Withdrawn | Feasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impairments | November 1, 2018 | May 30, 2020 | |
| NCT04674163 | Withdrawn | N/A | Expression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases. | January 2023 | January 2023 |
| NCT02459808 | Withdrawn | Gastrointestinal Transit Time in Patients With Guillain-Barré Syndrome | May 2015 |
- Disase is a (Disease Ontology)
- DOID:0060033
- Cross Reference ID (Disease Ontology)
- GARD:6554
- Cross Reference ID (Disease Ontology)
- ICD10CM:G61.0
- Cross Reference ID (Disease Ontology)
- MESH:D020275
- Cross Reference ID (Disease Ontology)
- MIM:139393
- Cross Reference ID (Disease Ontology)
- NCI:C116345
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:155082001
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0018378
- Exact Synonym (Disease Ontology)
- acute infective polyneuritis
- Exact Synonym (Disease Ontology)
- acute inflammatory demyelinating polyradiculopathy
- Exact Synonym (Disease Ontology)
- acute postinfectious polyneuropathy
- Exact Synonym (Disease Ontology)
- Infectious neuronitis
- Exact Synonym (Disease Ontology)
- Post-infectious polyneuritis
- Exact Synonym (Disease Ontology)
- Postinfectious polyneuritis
- MeSH unique ID (MeSH (Medical Subject Headings))
- D020275